Platelet‐activating factor: an endogenous mediator for bowel necrosis in endotoxemia
- 1 November 1987
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 1 (5) , 403-405
- https://doi.org/10.1096/fasebj.1.5.3678700
Abstract
We have developed a model of isochemic bowel necrosis in the rat by injecting platelet-activating factor (PAF) or PAF in combination with bacterial endotoxin. PAF causes profound hypotension, and it has been suggested that it is released during endotoxin shock. Because ischemic bowel necrosis is often associated with shock or infection, it is possible that PAF is the endogenous mediator that causes shock and bowel necrosis during sepsis. In this study, we have demonstrated that: 1) normal intestine contained a small amount of PAF; 2) necrotic lesions of the intestine could be induced by endotoxin injection; 3) PAF production in the bowel is markedly increased in animals treated with endotoxin; 4) pretreatment of the animal with PAF antagonists prevent endotoxin-induced necrosis; 5) isolated, buffer-perfused small intestine produced a small quantity of PAF in response to endotoxin injection. Therefore, we conclude that PAF is a likely endogenous mediator in endotoxemia, which causes bowel necrosis and shock.—Hsueh, W.; González-Crussi, F.; Arroyave, J. L. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J. 1: 403-405; 1987.Keywords
This publication has 14 references indexed in Scilit:
- Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1984
- The release of platelet-activating factor from human endothelial cells in culture.The Journal of Immunology, 1983
- EXPERIMENTAL-MODEL OF ISCHEMIC BOWEL NECROSIS - THE ROLE OF PLATELET-ACTIVATING FACTOR AND ENDOTOXIN1983
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- Platelet-activating factor (PAF-acether) and macrophagesCellular Immunology, 1981
- RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) AND HISTAMINE .2. THE CELLULAR-ORIGIN OF HUMAN-PAF - MONOCYTES, POLYMORPHONUCLEAR NEUTROPHILS AND BASOPHILS1981
- Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.The Journal of Immunology, 1980
- RESPIRATORY AND CIRCULATORY ALTERATIONS INDUCED BY ACETYL GLYCERYL ETHER PHOSPHORYLCHOLINE, A MEDIATOR OF IGE ANAPHYLAXIS IN THE RABBITPublished by Elsevier ,1980
- Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophilsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Physicochemical and Functional Identity of Rabbit Platelet-Activating Factor (PAF) Released in Vivo during IgE Anaphylaxis with PAF Released in Vitro from IgE Sensitized BasophilsThe Journal of Immunology, 1979